All In Biotech

Drug Trial Radar · NCT07848893

To Evaluate the Safety and Efficacy of RNK08954 in Patients With Advanced Gynecological Tumors.

A Phase II Clinical Study to Evaluate RNK08954 in Participants With Advanced Gynecologic Malignancies Harboring the KRAS G12D Mutation

Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Sep 15, 2026

Primary completion

Aug 31, 2028

Study completion Aug 31, 2028

Sponsor

Lead sponsor
Ranok Therapuetics Co. Ltd.Industry
Sponsor type
Industry
First posted
Sep 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, open-label, phase II clinical study to evaluate the safety and preliminary efficacy of RNK08954 in patients with advanced gynecological tumors

Conditions

  • Advanced Gynecologic Malignancies

Interventions

  • RNK08954Drug

    RNK08954 will be administered at the assigned dose level, orally, until disease progression or intolerable toxicity.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ORRTime frame: Up to 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.